跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TERIFLUNOMIDA KRKA 14 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TERIFLUNOMIDA KRKA 14 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
TERIFLUNOMIDA KRKA 14 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Krka D.D. Novo Mesto
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 31, 2023
Approval ID
b87b8c82cd2fa9e0
Company
Krka D.D. Novo Mesto
Type
Standard
Approval Details
Approval Id
b87b8c82cd2fa9e0
Drug Cima Aemps Name
TERIFLUNOMIDA KRKA 14 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
88753
Holder Company Name
Krka D.D. Novo Mesto
Marketing Company Name
Krka Farmaceutica S.L.
Authorization Date
2023-03-31
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
14 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Krka D.D. Novo Mesto
Active Ingredients
TERIFLUNOMIDA
14 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 31, 2023
Approval ID
b87b8c82cd2fa9e0
Type
Standard
Back to CIMA-AEMPS Approvals